Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 5;35(4):237-250.
doi: 10.1515/medgen-2023-2056. eCollection 2023 Dec.

Clinical application of circulating tumor cells

Nikolas H Stoecklein  1 , Julia Oles  1 , Andre Franken  2 , Hans Neubauer  2 , Leon W M M Terstappen  1 , Rui P L Neves  1
Affiliations

Clinical application of circulating tumor cells

Nikolas H Stoecklein et al. Med Genet. .

Abstract

This narrative review aims to provide a comprehensive overview of the current state of circulating tumor cell (CTC) analysis and its clinical significance in patients with epithelial cancers. The review explores the advancements in CTC detection methods, their clinical applications, and the challenges that lie ahead. By examining the important research findings in this field, this review offers the reader a solid foundation to understand the evolving landscape of CTC analysis and its potential implications for clinical practice. The comprehensive analysis of CTCs provides valuable insights into tumor biology, treatment response, minimal residual disease detection, and prognostic evaluation. Furthermore, the review highlights the potential of CTCs as a non-invasive biomarker for personalized medicine and the monitoring of treatment efficacy. Despite the progress made in CTC research, several challenges such as standardization, validation, and integration into routine clinical practice remain. The review concludes by discussing future directions and the potential impact of CTC analysis on improving patient outcomes and guiding therapeutic decision-making in epithelial cancers.

Keywords: CSF; CTCs; Circulating Tumor Cells; clinical relevance; prediction.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Overview of sample types processed wit CTC technologies and possibilities for subsequent analysis (designed with BioRender).
None
None
None
None
None
None
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ashworth TR. A Case of Cancer in Which Cells Similar to Those in the Tumors Were Seen in the Blood after Death. Medical Journal of Australia. 1869. pp. 146–149. 14:
    1. Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev Mol Diagn. 2016. pp. 147–164. 16: - PubMed
    1. Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW, Gratama JW, Sleijfer S, Foekens JA. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat. 2009. pp. 455–468. 118: - PubMed
    1. Lianidou ES, Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem. 2011. pp. 1242–1255. 57: - PubMed
    1. Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, Koscuiszka M, Vaananen RM, Pettersson K, Chun FK. Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem. 2009. pp. 765–773. et al. 55: - PMC - PubMed

LinkOut - more resources